Page last updated: 2024-09-03

(3-dimyristyloxypropyl)(dimethyl)(hydroxyethyl)ammonium and Sarcoma

(3-dimyristyloxypropyl)(dimethyl)(hydroxyethyl)ammonium has been researched along with Sarcoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akporiaye, ET; Burch, P; Edmonson, J; Forscher, C; Galanis, E; Gonzalez, R; Hersh, EM; Lewis, BD; O'Driscoll, M; Rinehart, JJ; Rubin, J; Selk, L; Sobol, RE; Sondak, VK; Spier, C; Stopeck, AT; Unger, EC1

Trials

1 trial(s) available for (3-dimyristyloxypropyl)(dimethyl)(hydroxyethyl)ammonium and Sarcoma

ArticleYear
Immunotherapy of advanced malignancy by direct gene transfer of an interleukin-2 DNA/DMRIE/DOPE lipid complex: phase I/II experience.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1999, Volume: 17, Issue:10

    Topics: Adult; Aged; Carcinoma, Renal Cell; CD8 Antigens; Dose-Response Relationship, Drug; Female; Gene Transfer Techniques; Genetic Therapy; Humans; Immunohistochemistry; Interleukin-2; Kidney Neoplasms; Lipids; Male; Melanoma; Middle Aged; Plasmids; Polymerase Chain Reaction; Quaternary Ammonium Compounds; Sarcoma; Skin Neoplasms

1999